Business Description
COSMOS Pharmaceutical Corp
ISIN : JP3298400007
Share Class Description:
TSE:3349: Ordinary SharesCompare
Compare
Traded in other countries / regions
3349.JapanCSMYF.USA IPO Date
2004-11-11Description
COSMOS Pharmaceutical Corp manages retail drugstores in Japan. The company places a strong emphasis on convenience regarding its product selection, which includes medical products, health and beauty aids, personal-care items, discount cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, alcoholic beverages, tobacco, insect repellent, and miscellaneous everyday consumables. The majority of the company's revenue is derived from common grocery sales. Cosmos also operates a private grocery brand called ON 365.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.61 | |||||
| Equity-to-Asset | 0.51 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | 0.33 | |||||
| Interest Coverage | 452.87 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 4.4 | |||||
| Beneish M-Score | -2.71 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6.5 | |||||
| 3-Year EBITDA Growth Rate | 4.5 | |||||
| 3-Year EPS without NRI Growth Rate | 2.5 | |||||
| 3-Year FCF Growth Rate | -41.8 | |||||
| 3-Year Book Growth Rate | 13.2 | |||||
| Future 3-5Y Total Revenue Growth Rate | 9.92 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 83.15 | |||||
| 9-Day RSI | 71.86 | |||||
| 14-Day RSI | 63.34 | |||||
| 6-1 Month Momentum % | 0.32 | |||||
| 12-1 Month Momentum % | 9.75 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.67 | |||||
| Quick Ratio | 0.24 | |||||
| Cash Ratio | 0.15 | |||||
| Days Inventory | 37.27 | |||||
| Days Sales Outstanding | 0.17 | |||||
| Days Payable | 75.47 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.8 | |||||
| Dividend Payout Ratio | 0.19 | |||||
| 3-Year Dividend Growth Rate | 22.1 | |||||
| Forward Dividend Yield % | 0.81 | |||||
| 5-Year Yield-on-Cost % | 1.77 | |||||
| Shareholder Yield % | -0.33 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 19.65 | |||||
| Operating Margin % | 3.38 | |||||
| Net Margin % | 2.66 | |||||
| FCF Margin % | 0.83 | |||||
| ROE % | 11.83 | |||||
| ROA % | 6.07 | |||||
| ROIC % | 7.5 | |||||
| ROC (Joel Greenblatt) % | 12.63 | |||||
| ROCE % | 15.38 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 23.51 | |||||
| PE Ratio without NRI | 23.41 | |||||
| Shiller PE Ratio | 27.86 | |||||
| PEG Ratio | 3.55 | |||||
| PS Ratio | 0.63 | |||||
| PB Ratio | 2.65 | |||||
| Price-to-Tangible-Book | 2.65 | |||||
| Price-to-Free-Cash-Flow | 74.97 | |||||
| Price-to-Operating-Cash-Flow | 10.74 | |||||
| EV-to-EBIT | 16.4 | |||||
| EV-to-Forward-EBIT | 18.46 | |||||
| EV-to-EBITDA | 16.4 | |||||
| EV-to-Forward-EBITDA | 11.4 | |||||
| EV-to-Revenue | 0.61 | |||||
| EV-to-Forward-Revenue | 0.64 | |||||
| EV-to-FCF | 70.5 | |||||
| Price-to-Projected-FCF | 2.23 | |||||
| Price-to-DCF (Earnings Based) | 0.95 | |||||
| Price-to-DCF (FCF Based) | 4.65 | |||||
| Price-to-Median-PS-Value | 0.8 | |||||
| Price-to-Graham-Number | 1.68 | |||||
| Earnings Yield (Greenblatt) % | 6.1 | |||||
| FCF Yield % | 1.33 | |||||
| Forward Rate of Return (Yacktman) % | 7.93 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
COSMOS Pharmaceutical Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 936,706 | ||
| EPS (TTM) (円) | 627.871 | ||
| Beta | 0.18 | ||
| Volatility % | 25.28 | ||
| 14-Day RSI | 63.34 | ||
| 14-Day ATR (円) | 385.026232 | ||
| 20-Day SMA (円) | 14079.5 | ||
| 12-1 Month Momentum % | 9.75 | ||
| 52-Week Range (円) | 12600 - 17440 | ||
| Shares Outstanding (Mil) | 39.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
COSMOS Pharmaceutical Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
COSMOS Pharmaceutical Corp Stock Events
| Event | Date | Price(円) | ||
|---|---|---|---|---|
| No Event Data | ||||
COSMOS Pharmaceutical Corp Frequently Asked Questions
What is COSMOS Pharmaceutical Corp(TSE:3349)'s stock price today?
The current price of TSE:3349 is 円14765.00. The 52 week high of TSE:3349 is 円17440.00 and 52 week low is 円12600.00.
When is next earnings date of COSMOS Pharmaceutical Corp(TSE:3349)?
The next earnings date of COSMOS Pharmaceutical Corp(TSE:3349) is .
Does COSMOS Pharmaceutical Corp(TSE:3349) pay dividends? If so, how much?
The Dividend Yield %  of COSMOS Pharmaceutical Corp(TSE:3349) is 0.8% (As of Today), Highest Dividend Payout Ratio of COSMOS Pharmaceutical Corp(TSE:3349) was 0.19. The lowest was 0.09. And the median was 0.1. The  Forward Dividend Yield % of COSMOS Pharmaceutical Corp(TSE:3349) is 0.81%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers